EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma

Dong-Gun Kim, Eun-Young Choi, Hye-Mi Ahn, Youn-Jae Kim

Cells · 2024

DOI: 10.3390/cells13242128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Dong-Gun Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Targeted Therapy Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Neoplasm Metastasis, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastasis is a leading cause of lung adenocarcinoma (LUAD)-related mortality and presents significant challenges for treatment. The gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor (GPCR) family, has an unclear role in LUAD progression. This study aimed to investigate the function and underlying mechanisms of GRPR in LUAD metastasis. Our findings revealed that GRPR levels were significantly elevated in tumor tissues, and higher GRPR expression was associated with worse overall survival outcomes. Functional assays demonstrated that GRPR overexpression enhanced LUAD cell invasion, while GRPR knockdown inhibited invasion both in vitro and in vivo. RNA sequencing and gene set enrichment analysis (GSEA) identified an enrichment of metastasis-promoting genes in GRPR-overexpressing cells, with CRABP2 and FNDC4 emerging as key targets. Clinical analyses further confirmed a positive correlation between GRPR expression and the levels of CRABP2 and FNDC4 in LUAD patients. These results suggest that GRPR could serve as both a prognostic marker and a therapeutic target to inhibit metastasis in LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsNeoplasm MetastasisGene Expression Regulation, NeoplasticHumansCell Line, TumorMaleAnimalsFemaleSignal TransductionMiceFibronectinsMiddle AgedMice, NudePrognosisMice, Inbred BALB CNeoplasm InvasivenessReceptors, Retinoic Acid

Stichwörter der Autor:innen

AKTCRAPB2FNCD4GRPRlung adenocarcinomametastasis

Substanzen

retinoic acid binding protein II, cellularFibronectinsReceptors, Retinoic Acid

Autor:innen und Institutionen

  • Targeted Therapy Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.

Förderung

  • National Cancer Center

Zitieren

APA

Kim, D. G., Choi, E. Y., Ahn, H. M., & Kim, Y. J. (2024). GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma. Cells. https://doi.org/10.3390/cells13242128

Vancouver

Kim DG, Choi EY, Ahn HM, Kim YJ. GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma. Cells. 2024. doi:10.3390/cells13242128

BibTeX
@article{Kim2024,
  author = {Kim, Dong-Gun and Choi, Eun-Young and Ahn, Hye-Mi and Kim, Youn-Jae},
  title = {GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13242128}
}
Kostenlos starten →